While 2023 and into 2024 might have been some of the most challenging times for Marinette’s Dan Buyarski and his health, ...

Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had an overall mortality rate of just 8.1% at one year, well below the trial's ...

Medtronic, Abbott and Boston Scientific had updates on their devices used in heart valve disease treatment at the event.

Transcatheter Aortic Valve Replacement Market outlook through 2035, highlighting key trends, growth drivers, challenges, and future opportunities ...

BACKGROUND: Real-world low-risk transcatheter aortic valve replacement (TAVR) outcomes in the United States have not been assessed comprehensively versus pivotal trials, which is a key component of ...

Dapagliflozin reduced the risk of death or worsening heart failure in older patients with aortic stenosis who underwent transcatheter aortic-valve implantation.

A device in clinical development appears to be far safer and more effective than the TAVI devices currently being used ...

The “passive” notification led to more patients with severe AS undergoing valve replacement, but more can be done still.

TAVR is an advanced, less-invasive treatment option for patients with aortic ... without open-heart surgery when they completed their first transcatheter aortic valve replacement (TAVR) in late ...

BACKGROUND: Despite reported racial disparities between Black and White adults in short-term outcomes after abdominal aortic ...

The researchers noted several limitations of the DapaTAVI trial, including its pragmatic and open-label design ... older patients undergoing aortic valve replacement, we found clinically relevant ...

Cardiothoracic Surgeon Geoffrey R. Cousins, MD, FACS, left, and Interventional Cardiologist Jason Schott, DO, mark the 100th transcatheter aortic valve replacement procedure performed at Memorial ...